AlphaQuest LLC decreased its position in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 97.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The ...

Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...

Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments ...

Scholar Rock (NASDAQ:SRRK – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on ...

In this article, we are going to take a look at where Scholar Rock Holding Corporation (NASDAQ:SRRK) stands against the other stocks. One of the strongest stock market anomalies is the momentum ...

Scholar Rock Holding Corporation (NASDAQ ... Street analysts have given the stock a Strong Buy rating. Overall, SRRK ranks 9th on our list of oversold biotech stocks to buy now.

Investors considering a purchase of Scholar Rock Holding Corp (Symbol: SRRK) stock, but cautious about paying the going market price of $37.22/share, might benefit from considering selling puts ...

In a regulatory filing, Scholar Rock (SRRK) CEO Jay Backstrom disclosed ... and streamline your search for investment opportunities with TipRanks’ Stock Screener. Published first on TheFly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Based on Scholar Rock Holding’s latest earnings release ... corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders ...

The inducement stock options have an exercise price of $35.15, which is equal to the closing price of Scholar Rock’s common stock on March 10, 2025. The inducement stock options will vest with ...